Kangmei Pharmaceutical Statistics
Total Valuation
SHA:600518 has a market cap or net worth of CNY 28.07 billion. The enterprise value is 27.31 billion.
Market Cap | 28.07B |
Enterprise Value | 27.31B |
Important Dates
The last earnings date was Saturday, August 30, 2025.
Earnings Date | Aug 30, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SHA:600518 has 13.83 billion shares outstanding. The number of shares has increased by 33.39% in one year.
Current Share Class | 13.83B |
Shares Outstanding | 13.83B |
Shares Change (YoY) | +33.39% |
Shares Change (QoQ) | +197.41% |
Owned by Insiders (%) | 0.00% |
Owned by Institutions (%) | 11.47% |
Float | 9.99B |
Valuation Ratios
The trailing PE ratio is 2,889.70.
PE Ratio | 2,889.70 |
Forward PE | n/a |
PS Ratio | 5.30 |
PB Ratio | 3.88 |
P/TBV Ratio | 4.20 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 2,811.27 |
EV / Sales | 5.16 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -108.56 |
Financial Position
The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.01.
Current Ratio | 1.20 |
Quick Ratio | 0.73 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | -0.41 |
Interest Coverage | -17.93 |
Financial Efficiency
Return on equity (ROE) is 0.17% and return on invested capital (ROIC) is -2.82%.
Return on Equity (ROE) | 0.17% |
Return on Assets (ROA) | -1.48% |
Return on Invested Capital (ROIC) | -2.82% |
Return on Capital Employed (ROCE) | -4.19% |
Revenue Per Employee | 1.25M |
Profits Per Employee | 2,295 |
Employee Count | 4,233 |
Asset Turnover | 0.38 |
Inventory Turnover | 1.69 |
Taxes
In the past 12 months, SHA:600518 has paid 26.08 million in taxes.
Income Tax | 26.08M |
Effective Tax Rate | 67.99% |
Stock Price Statistics
The stock price has increased by +15.34% in the last 52 weeks. The beta is 0.63, so SHA:600518's price volatility has been lower than the market average.
Beta (5Y) | 0.63 |
52-Week Price Change | +15.34% |
50-Day Moving Average | 2.06 |
200-Day Moving Average | 2.15 |
Relative Strength Index (RSI) | 44.36 |
Average Volume (20 Days) | 300,892,466 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:600518 had revenue of CNY 5.29 billion and earned 9.71 million in profits. Earnings per share was 0.00.
Revenue | 5.29B |
Gross Profit | 778.68M |
Operating Income | -330.39M |
Pretax Income | 38.36M |
Net Income | 9.71M |
EBITDA | -52.87M |
EBIT | -330.39M |
Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 902.71 million in cash and 104.34 million in debt, giving a net cash position of 798.37 million or 0.06 per share.
Cash & Cash Equivalents | 902.71M |
Total Debt | 104.34M |
Net Cash | 798.37M |
Net Cash Per Share | 0.06 |
Equity (Book Value) | 7.23B |
Book Value Per Share | 0.28 |
Working Capital | 1.15B |
Cash Flow
In the last 12 months, operating cash flow was -190.89 million and capital expenditures -60.68 million, giving a free cash flow of -251.57 million.
Operating Cash Flow | -190.89M |
Capital Expenditures | -60.68M |
Free Cash Flow | -251.57M |
FCF Per Share | -0.02 |
Margins
Gross margin is 14.71%, with operating and profit margins of -6.24% and 0.18%.
Gross Margin | 14.71% |
Operating Margin | -6.24% |
Pretax Margin | 0.72% |
Profit Margin | 0.18% |
EBITDA Margin | -1.00% |
EBIT Margin | -6.24% |
FCF Margin | n/a |
Dividends & Yields
SHA:600518 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 8.19% |
Buyback Yield | -33.39% |
Shareholder Yield | n/a |
Earnings Yield | 0.03% |
FCF Yield | -0.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on June 16, 2015. It was a forward split with a ratio of 2.
Last Split Date | Jun 16, 2015 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |